LBL Chart by TradingView

Business Description

Lattice Biologics Ltd. (“Lattice”, “company”), based out of Scottsdale, Arizona, is an emerging player in the field of natural and regenerative tissue engineering for bone, skin, and cartilage, as well as novel products related to cancer diagnostics.


FRC Analyst's Reports

Lattice Biologics (TSXV: LBL / OTCBB: BLVKF): Strengthens Pipeline Sep. 7, 2016
Lattice Biologics (TSXV: LBL) New product sales growing Jun. 6, 2016
Lattice Biologics (TSXV: LBL / OTCBB: BLVKF): Initiating; Regenerative Medicine May. 11, 2016


Lattice Unaware of Any Material Change Jan. 6, 2021
COVID19 UPDATE – Lattice Biologics Announces Cessation of Patient Recruitment Sep. 3, 2020
Lattice Biologics Ltd. Reports Q3 2020 Results Aug. 31, 2020
Lattice Biologics Issues Shares and Warrants Aug. 18, 2020
Lattice Biologics Eliminates CAN$838,000 in Debt Jun. 8, 2020